Edwards Lifesciences Corporation (NYSE:EW) Q4 2023 Earnings Call Transcript February 6, 2024 Edwards Lifesciences Corporation misses on earnings expectations. Reported EPS is $0.609 EPS, expectations were $0.64. EW isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to […]
Related Keywords
Mark Wilterding , Scott Ullem , Bernard Zovighian , Medtronic , Critical Care , Smart Recovery , Hypotension Prediction Index , Smart Expansion , Surgical Structural Heart , Stress High Paying Jobs In The , Tavr , Emtt , Growth Opportunities , Sales Growth , Edwards Lifesciences , Bernard , Fourth Quarter ,
vimarsana.com © 2020. All Rights Reserved.